US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Toyota

194.48

+2.481.29%

Pre-market: 196.712.23+1.15%07:22 EDT

Volume:427.85K

Turnover:83.20M

Market Cap:230.26B

PE:9.05

High:196.51

Open:196.08

Low:192.55

Close:192.00

52wk High:248.90

52wk Low:166.10

Shares:1.18B

Float Shares:1.09B

Volume Ratio:1.38

T/O Rate:0.04%

Dividend:5.95

Dividend Rate:3.06%

EPS(TTM):21.49

EPS(LYR):18.57

ROE:12.40%

ROA:2.34%

PB:0.99

PE(LYR):10.47

Loading ...

Overview Company News Filings

Press Release: Quoin Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2026 Financial Results

Press Release: Evaxion to Announce Business Update and Second Quarter 2026 Financial Results on August 20, 2026

Press Release: Lantern Pharma Reports Second Quarter 2026 Financial Results and Provides Business Update

Press Release: Milestone Scientific Reports Financial Results for Second Quarter 2026

Press Release: Helus Pharma Reports First Quarter Fiscal 2027 Financial Results and Recent Business Highlights

Press Release: Payward Reports Second Quarter 2026 Adjusted Revenue of $508 Million, up 17% Year over Year

Press Release: Quantum BioPharma Strengthens Equity and Liquidity in Q2 2026 as FDA Approves Lucid-MS for Pivotal Phase 2 Clinical Trial

Press Release: BTQ Technologies Announces 2026 AGM Results

Press Release: Genelux Corporation Reports Second Quarter Financial Results and Provides Business Updates

Press Release: Tri Pointe Homes, Inc. Reports 2026 Second Quarter Results

Press Release: Xos Extends Gross Profit Streak, Highlighting Operational Efficiency

Press Release: Celcuity Inc. Reports Release of Second Quarter 2026 Financial Results and Provides Corporate Update

Press Release: Quantum-Si Reports Second Quarter 2026 Financial Results and Provides Proteus(TM) Development Update

Press Release: Swarmer Reports Second Quarter 2026 Financial Results and Provides Business Update

Press Release: Vivani Medical Reports Second Quarter 2026 Financial Results and Provides Business Update

Press Release: Fortress Biotech Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights

Press Release: CapsoVision Reports Second Quarter 2026 Financial Results

Press Release: Kyntra Bio Reports Second Quarter 2026 Financial Results and Provides Business Update

Press Release: Cingulate Inc. Reports Second Quarter 2026 Financial Results and Provides Update on CTx-1301 CMC Progress Towards NDA Resubmission and Commercial Readiness

Press Release: Bragg Gaming Group Reports Second Quarter 2026 Financial Results

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/TM/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TM\",,,,,undefined,":{"symbol":"TM","market":"US","secType":"STK","nameCN":"Toyota","latestPrice":194.48,"timestamp":1787947200000,"preClose":192,"halted":0,"volume":427847,"hourTrading":{"tag":"盘前","latestPrice":196.7136,"preClose":194.48,"latestTime":"07:22 EDT","volume":343,"amount":67520.07136,"timestamp":1788175345575,"change":2.2336,"changeRate":0.011485,"amplitude":0.029592},"delay":0,"changeRate":0.012916666666666613,"floatShares":1091996400,"shares":1184000000,"eps":21.492434,"marketStatus":"Pre-Mkt","change":2.48,"latestTime":"08-31 07:31:03 EDT","open":196.08,"high":196.51,"low":192.55,"amount":83198391.72316,"amplitude":0.020625,"askPrice":197,"askSize":2,"bidPrice":196.01,"bidSize":10,"shortable":3,"etf":0,"ttmEps":21.492434,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788183000000},"marketStatusCode":1,"adr":1,"adrRate":10,"listingDate":938577600000,"exchange":"NYSE","adjPreClose":194.48,"dividendRate":0.030955,"preHourTrading":{"tag":"盘前","latestPrice":196.7136,"preClose":194.48,"latestTime":"07:22 EDT","volume":343,"amount":67520.07136,"timestamp":1788175345575,"change":2.2336,"changeRate":0.011485,"amplitude":0.029592},"postHourTrading":{"tag":"盘后","latestPrice":194.82,"preClose":194.48,"latestTime":"19:58 EDT","volume":5084,"amount":988929.545,"timestamp":1787961501651,"change":0.34,"changeRate":0.001748,"amplitude":0.001748},"volumeRatio":1.3778492712177717,"impliedVol":0.2229,"impliedVolPercentile":0.004},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TM\",,,,,undefined,":{"symbol":"TM","floatShares":1091996400,"roa":"2.34%","roe":"12.40%","lyrEps":18.568556,"volumeRatio":1.3778492712177717,"shares":1184000000,"dividePrice":5.94985,"high":196.51,"amplitude":0.020625,"preClose":192,"low":192.55,"week52Low":166.1,"pbRate":"0.99","psRate":"0.71","week52High":248.9,"institutionHeld":0.1843,"latestPrice":194.48,"committee":0.666667,"eps":21.492434,"divideRate":0.030594,"volume":427847,"delay":0,"ttmEps":21.492434,"open":196.08,"prevYearClose":214.06,"prevWeekClose":194.48,"prevMonthClose":188.99,"prevQuarterClose":168.42,"fiveDayClose":197.35,"twentyDayClose":188.99,"sixtyDayClose":180.22,"dividendPayoutRate":1.3265738484248728,"dividendGrowthYears":0,"dividendGrowthRate":-0.5603196929755107,"fiveYearAvgDividendRate":0.022280239884563},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TM\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-04","symbol":"TM","fiscalQuarterEnding":"2026/06","expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785816000000,"reportTimeType":"pre","actualEps":7.57},{"market":"US","date":"2026-05-08","symbol":"TM","fiscalQuarterEnding":"2026/03","expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778212800000,"reportTimeType":"pre","actualEps":4},{"date":"2026-02-06","symbol":"TM","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1770368400000,"name":null,"time":"Pre-MKt","dateTimestamp":1770354000000,"actualEps":null},{"market":"US","date":"2025-11-05","symbol":"TM","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762318800000,"reportTimeType":"pre","actualEps":4.85},{"market":"US","date":"2025-08-07","symbol":"TM","fiscalQuarterEnding":"2025/06","expectedEps":4.67,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"pre","actualEps":4.47}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TM\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-28","recordDate":"2016-09-30","paymentDate":"2016-12-09","value":1.569363,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TM\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.5,"hold":0,"sell":0.1667,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":6,"updateTime":1778817600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TM\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TM","date":"2026-08-28","current":9.048766,"percent":0.190596,"low":5.801283,"twenty":8.292471,"median":9.643002,"eighty":10.611709,"high":13.909472,"avg":9.495081,"sd":1.478929,"marketCap":231621473400.96},"quantilePoints":[{"date":"2021-09-03","current":9.063413,"twenty":8.393326,"median":10.004604,"eighty":12.01051,"marketCap":246637389214.94},{"date":"2021-09-10","current":9.252002,"twenty":8.394908,"median":10.002518,"eighty":12.004072,"marketCap":251288150621.92},{"date":"2021-09-17","current":9.308671,"twenty":8.396048,"median":9.99775,"eighty":11.994408,"marketCap":252799709406.21},{"date":"2021-09-24","current":9.382992,"twenty":8.403792,"median":9.986261,"eighty":11.987415,"marketCap":252923794576.82},{"date":"2021-10-01","current":9.12927,"twenty":8.409387,"median":9.973917,"eighty":11.971261,"marketCap":245304629508.38},{"date":"2021-10-08","current":8.925056,"twenty":8.410028,"median":9.964878,"eighty":11.960601,"marketCap":237531091007.3},{"date":"2021-10-15","current":9.252262,"twenty":8.428607,"median":9.962049,"eighty":11.82452,"marketCap":241843777339.12},{"date":"2021-10-22","current":9.20585,"twenty":8.440923,"median":9.952345,"eighty":11.645716,"marketCap":241593442858.66},{"date":"2021-10-29","current":9.312598,"twenty":8.443706,"median":9.948053,"eighty":11.561919,"marketCap":243634285432.24},{"date":"2021-11-05","current":8.975461,"twenty":8.445805,"median":9.935016,"eighty":11.532678,"marketCap":248501922540.45},{"date":"2021-11-12","current":9.16732,"twenty":8.454705,"median":9.910445,"eighty":11.523333,"marketCap":252793124084.94},{"date":"2021-11-19","current":9.405489,"twenty":8.461877,"median":9.899061,"eighty":11.517377,"marketCap":259527117928.35},{"date":"2021-11-26","current":9.149677,"twenty":8.466559,"median":9.894628,"eighty":11.512447,"marketCap":253479623869.98},{"date":"2021-12-03","current":9.160058,"twenty":8.475021,"median":9.887521,"eighty":11.505169,"marketCap":254400083471.97},{"date":"2021-12-10","current":9.041096,"twenty":8.480033,"median":9.88412,"eighty":11.493229,"marketCap":250566573719.52},{"date":"2021-12-17","current":9.263599,"twenty":8.484548,"median":9.86767,"eighty":11.48171,"marketCap":256097965039.75},{"date":"2021-12-23","current":9.237163,"twenty":8.490174,"median":9.859408,"eighty":11.471221,"marketCap":253647768358.79},{"date":"2021-12-31","current":9.276817,"twenty":8.493551,"median":9.854997,"eighty":11.456034,"marketCap":253024211561.73},{"date":"2022-01-07","current":10.166827,"twenty":8.496303,"median":9.855048,"eighty":11.431774,"marketCap":276004685092.89},{"date":"2022-01-14","current":10.516828,"twenty":8.503793,"median":9.859806,"eighty":11.425102,"marketCap":290098154445},{"date":"2022-01-21","current":10.052591,"twenty":8.517735,"median":9.870881,"eighty":11.424469,"marketCap":277446097986.58},{"date":"2022-01-28","current":9.843575,"twenty":8.539835,"median":9.860203,"eighty":11.409941,"marketCap":268403226005.71},{"date":"2022-02-04","current":10.011773,"twenty":8.541824,"median":9.870881,"eighty":11.399135,"marketCap":272821257021.9},{"date":"2022-02-11","current":10.058874,"twenty":8.54339,"median":9.88412,"eighty":11.396131,"marketCap":268450027193.42},{"date":"2022-02-18","current":9.746486,"twenty":8.54339,"median":9.859806,"eighty":11.396131,"marketCap":261873033011.99},{"date":"2022-02-25","current":9.389472,"twenty":8.54339,"median":9.853459,"eighty":11.396131,"marketCap":251241883575.67},{"date":"2022-03-04","current":8.799364,"twenty":8.54339,"median":9.845856,"eighty":11.396131,"marketCap":237284744492.84},{"date":"2022-03-11","current":8.288067,"twenty":8.499307,"median":9.844533,"eighty":11.396131,"marketCap":218913247941.31},{"date":"2022-03-18","current":8.9986,"twenty":8.499307,"median":9.836624,"eighty":11.396131,"marketCap":233634975165.39},{"date":"2022-03-25","current":9.75293,"twenty":8.499307,"median":9.828189,"eighty":11.396131,"marketCap":247249672929.23},{"date":"2022-04-01","current":9.824217,"twenty":8.499307,"median":9.828189,"eighty":11.396131,"marketCap":247460850931.08},{"date":"2022-04-08","current":9.334918,"twenty":8.499307,"median":9.831145,"eighty":11.396131,"marketCap":232235123302.67},{"date":"2022-04-14","current":9.495289,"twenty":8.499307,"median":9.831145,"eighty":11.396131,"marketCap":233257145582.12},{"date":"2022-04-22","current":9.844986,"twenty":8.499307,"median":9.839797,"eighty":11.396131,"marketCap":236599907147.33},{"date":"2022-04-29","current":9.958582,"twenty":8.499307,"median":9.840723,"eighty":11.396131,"marketCap":237347675531.69},{"date":"2022-05-06","current":10.138999,"twenty":8.499307,"median":9.845088,"eighty":11.396131,"marketCap":240796093234.38},{"date":"2022-05-13","current":9.902689,"twenty":8.499307,"median":9.845841,"eighty":11.396131,"marketCap":218406153199.98},{"date":"2022-05-20","current":9.868957,"twenty":8.499307,"median":9.850202,"eighty":11.396131,"marketCap":219985877217.54},{"date":"2022-05-27","current":10.042435,"twenty":8.499307,"median":9.857177,"eighty":11.396131,"marketCap":225205518526.56},{"date":"2022-06-03","current":10.43276,"twenty":8.499307,"median":9.871524,"eighty":11.396131,"marketCap":227442854072.09},{"date":"2022-06-10","current":10.618285,"twenty":8.499307,"median":9.881378,"eighty":11.396131,"marketCap":225527280701.5},{"date":"2022-06-17","current":9.94124,"twenty":8.499307,"median":9.886852,"eighty":11.396131,"marketCap":209613208799.02},{"date":"2022-06-24","current":10.174953,"twenty":8.498306,"median":9.898721,"eighty":11.396882,"marketCap":214650672075.96},{"date":"2022-07-01","current":9.960515,"twenty":8.498306,"median":9.910445,"eighty":11.396882,"marketCap":209955949125.43},{"date":"2022-07-08","current":10.16347,"twenty":8.498306,"median":9.925171,"eighty":11.396882,"marketCap":212820567269.74},{"date":"2022-07-15","current":10.413825,"twenty":8.498306,"median":9.925171,"eighty":11.396882,"marketCap":214317007818.47},{"date":"2022-07-22","current":10.603999,"twenty":8.498306,"median":9.94124,"eighty":11.396882,"marketCap":222014152586.22},{"date":"2022-07-29","current":10.288648,"twenty":8.498306,"median":9.950148,"eighty":11.396882,"marketCap":219757471716.45},{"date":"2022-08-05","current":10.806112,"twenty":8.498306,"median":9.958582,"eighty":11.396882,"marketCap":214624780320.42},{"date":"2022-08-12","current":10.867192,"twenty":8.498306,"median":9.962049,"eighty":11.396882,"marketCap":218729696330.85},{"date":"2022-08-19","current":10.943542,"twenty":8.498306,"median":9.99775,"eighty":11.396882,"marketCap":214673171486.83},{"date":"2022-08-26","current":10.729761,"twenty":8.498306,"median":10.002981,"eighty":11.396882,"marketCap":210252561069.66},{"date":"2022-09-02","current":10.42945,"twenty":8.498306,"median":10.009884,"eighty":11.396882,"marketCap":200204255509.37},{"date":"2022-09-09","current":10.579606,"twenty":8.498306,"median":10.023176,"eighty":11.396882,"marketCap":199607069481.08},{"date":"2022-09-16","current":10.335285,"twenty":8.498306,"median":10.032798,"eighty":11.396882,"marketCap":194372829865.35},{"date":"2022-09-23","current":10.32256,"twenty":8.498306,"median":10.032798,"eighty":11.396882,"marketCap":193831215549.25},{"date":"2022-09-30","current":9.548877,"twenty":8.498306,"median":10.023176,"eighty":11.396882,"marketCap":177471819946.95},{"date":"2022-10-07","current":10.106181,"twenty":8.498306,"median":10.02316,"eighty":11.396882,"marketCap":187164770352.11},{"date":"2022-10-14","current":10.220706,"twenty":8.498306,"median":10.012625,"eighty":11.396882,"marketCap":185125554677.98},{"date":"2022-10-21","current":10.116361,"twenty":8.498306,"median":10.012625,"eighty":11.396882,"marketCap":183586764747.77},{"date":"2022-10-28","current":10.332686,"twenty":8.498306,"median":10.012625,"eighty":11.396882,"marketCap":188355275218.58},{"date":"2022-11-04","current":10.847885,"twenty":8.498306,"median":10.012625,"eighty":11.396882,"marketCap":184044729352.68},{"date":"2022-11-11","current":10.935324,"twenty":8.498306,"median":10.012625,"eighty":11.396882,"marketCap":196172673768.74},{"date":"2022-11-18","current":10.891604,"twenty":8.498306,"median":10.012625,"eighty":11.396882,"marketCap":194342479643.61},{"date":"2022-11-25","current":11.227697,"twenty":8.498306,"median":10.012625,"eighty":11.396882,"marketCap":201352566176.83},{"date":"2022-12-02","current":10.771376,"twenty":8.498306,"median":10.012625,"eighty":11.396882,"marketCap":198720186497.14},{"date":"2022-12-09","current":10.672344,"twenty":8.498306,"median":10.012625,"eighty":11.396882,"marketCap":195394464280.42},{"date":"2022-12-16","current":10.601341,"twenty":8.498306,"median":10.012625,"eighty":11.396882,"marketCap":193689705547.03},{"date":"2022-12-23","current":9.92954,"twenty":8.498306,"median":10.009884,"eighty":11.396882,"marketCap":186680586153.25},{"date":"2022-12-30","current":9.8995,"twenty":8.498306,"median":10.004188,"eighty":11.396882,"marketCap":187424120297.56},{"date":"2023-01-06","current":9.967773,"twenty":8.498306,"median":10.002518,"eighty":11.396882,"marketCap":187826513885.49},{"date":"2023-01-13","current":9.900927,"twenty":8.498306,"median":9.99775,"eighty":11.391839,"marketCap":193695001985.49},{"date":"2023-01-20","current":10.269042,"twenty":8.498306,"median":9.99775,"eighty":11.371547,"marketCap":197429750273.07},{"date":"2023-01-27","current":10.364479,"twenty":8.498306,"median":9.99775,"eighty":11.356276,"marketCap":199180241789.68},{"date":"2023-02-03","current":10.30012,"twenty":8.498306,"median":9.99775,"eighty":11.333641,"marketCap":196422447417.63},{"date":"2023-02-10","current":10.500354,"twenty":8.498306,"median":10.002518,"eighty":11.333641,"marketCap":194355374375.32},{"date":"2023-02-17","current":10.65962,"twenty":8.498306,"median":10.008162,"eighty":11.333641,"marketCap":192970903798.5},{"date":"2023-02-24","current":10.383001,"twenty":8.498306,"median":10.012625,"eighty":11.333641,"marketCap":185357918633.29},{"date":"2023-03-03","current":10.517526,"twenty":8.510764,"median":10.0275,"eighty":11.333641,"marketCap":187828381133.47},{"date":"2023-03-10","current":10.581708,"twenty":8.548174,"median":10.042435,"eighty":11.333641,"marketCap":190727411760.14},{"date":"2023-03-17","current":9.967791,"twenty":8.592191,"median":10.055161,"eighty":11.333641,"marketCap":183499755175.24},{"date":"2023-03-24","current":9.947037,"twenty":8.631375,"median":10.055161,"eighty":11.333641,"marketCap":185142028497.28},{"date":"2023-03-31","current":10.482303,"twenty":8.645153,"median":10.059123,"eighty":11.328108,"marketCap":191843639012.74},{"date":"2023-04-06","current":10.184004,"twenty":8.648723,"median":10.066202,"eighty":11.328108,"marketCap":188162070105.05},{"date":"2023-04-14","current":10.080853,"twenty":8.66463,"median":10.076589,"eighty":11.333641,"marketCap":185220967562.58},{"date":"2023-04-21","current":10.047399,"twenty":8.673795,"median":10.082108,"eighty":11.333641,"marketCap":182347845691.72},{"date":"2023-04-28","current":10.354062,"twenty":8.687916,"median":10.087954,"eighty":11.333641,"marketCap":188050875815.22},{"date":"2023-05-05","current":10.39588,"twenty":8.698992,"median":10.096155,"eighty":11.333641,"marketCap":188685008663.47},{"date":"2023-05-12","current":10.7467,"twenty":8.71352,"median":10.103167,"eighty":11.339175,"marketCap":196024816270.07},{"date":"2023-05-19","current":10.843542,"twenty":8.712564,"median":10.107669,"eighty":11.350241,"marketCap":191831714435.03},{"date":"2023-05-24","current":10.826941,"twenty":8.714955,"median":10.11015,"eighty":11.350241,"marketCap":190788985103.57},{"date":"2023-06-09","current":11.342728,"twenty":8.766683,"median":10.124788,"eighty":11.356641,"marketCap":200031894537.04},{"date":"2023-06-16","current":12.805147,"twenty":8.799234,"median":10.137578,"eighty":11.391839,"marketCap":223365019400.58},{"date":"2023-06-23","current":12.161019,"twenty":8.828227,"median":10.143938,"eighty":11.422196,"marketCap":208670959088.58},{"date":"2023-06-29","current":12.691802,"twenty":8.864323,"median":10.150966,"eighty":11.489152,"marketCap":215086680971.05},{"date":"2023-07-03","current":12.857672,"twenty":8.872176,"median":10.160675,"eighty":11.502548,"marketCap":218018238631.84},{"date":"2023-07-12","current":12.147683,"twenty":8.918218,"median":10.163979,"eighty":11.779334,"marketCap":215254189834.62},{"date":"2023-07-20","current":12.639559,"twenty":8.96426,"median":10.167277,"eighty":11.966324,"marketCap":220786122927.06},{"date":"2023-07-28","current":12.766673,"twenty":9.010002,"median":10.174767,"eighty":12.00188,"marketCap":221871351348.02},{"date":"2023-08-04","current":10.899958,"twenty":9.031492,"median":10.17782,"eighty":12.007361,"marketCap":231851878614.13},{"date":"2023-08-11","current":10.861948,"twenty":9.04236,"median":10.184004,"eighty":12.007361,"marketCap":227593958068.73},{"date":"2023-08-18","current":10.504206,"twenty":9.078146,"median":10.189579,"eighty":12.007361,"marketCap":217607210721.31},{"date":"2023-08-25","current":10.709908,"twenty":9.10278,"median":10.197801,"eighty":12.007361,"marketCap":222436604173.45},{"date":"2023-09-01","current":11.266644,"twenty":9.122869,"median":10.217604,"eighty":12.007361,"marketCap":234091178799.61},{"date":"2023-09-08","current":11.632383,"twenty":9.129306,"median":10.223034,"eighty":12.007361,"marketCap":239062167551.94},{"date":"2023-09-15","current":12.608824,"twenty":9.149677,"median":10.231608,"eighty":12.038468,"marketCap":259256210611.1},{"date":"2023-09-22","current":12.461352,"twenty":9.160246,"median":10.253921,"eighty":12.102922,"marketCap":255740860659.18},{"date":"2023-09-29","current":11.965312,"twenty":9.176462,"median":10.263466,"eighty":12.122846,"marketCap":242410597101.79},{"date":"2023-10-05","current":11.567214,"twenty":9.18527,"median":10.271329,"eighty":12.123833,"marketCap":235551857382.08},{"date":"2023-10-12","current":12.23713,"twenty":9.197232,"median":10.271457,"eighty":12.139596,"marketCap":247225582426.59},{"date":"2023-10-20","current":11.687799,"twenty":9.211776,"median":10.276468,"eighty":12.142831,"marketCap":235929020292.45},{"date":"2023-11-03","current":9.638628,"twenty":9.235475,"median":10.293128,"eighty":12.148482,"marketCap":247832080640.27},{"date":"2023-11-10","current":9.779528,"twenty":9.258366,"median":10.293128,"eighty":12.148482,"marketCap":250599077838.42},{"date":"2023-11-17","current":10.091789,"twenty":9.275495,"median":10.293128,"eighty":12.148482,"marketCap":259396028596.42},{"date":"2023-11-24","current":9.779528,"twenty":9.28243,"median":10.293128,"eighty":12.148482,"marketCap":252923781896.85},{"date":"2023-12-01","current":9.884197,"twenty":9.289465,"median":10.293128,"eighty":12.148482,"marketCap":258764509700.73},{"date":"2023-12-08","current":9.347202,"twenty":9.298314,"median":10.288648,"eighty":12.148216,"marketCap":250910555795.92},{"date":"2023-12-15","current":9.068233,"twenty":9.30405,"median":10.293128,"eighty":12.148482,"marketCap":247803779364.67},{"date":"2023-12-21","current":8.848545,"twenty":9.30405,"median":10.293128,"eighty":12.148482,"marketCap":238192449604.09},{"date":"2023-12-29","current":9.033362,"twenty":9.307273,"median":10.297791,"eighty":12.149015,"marketCap":247750139359.73},{"date":"2024-01-05","current":9.420431,"twenty":9.308671,"median":10.297973,"eighty":12.150743,"marketCap":252256823254.4},{"date":"2024-01-12","current":9.887005,"twenty":9.327923,"median":10.297973,"eighty":12.150743,"marketCap":261924877051.17},{"date":"2024-01-19","current":10.322632,"twenty":9.349294,"median":10.300942,"eighty":12.152471,"marketCap":269866492565.03},{"date":"2024-01-26","current":10.080423,"twenty":9.369845,"median":10.312289,"eighty":12.150743,"marketCap":264286074026.99},{"date":"2024-02-02","current":10.28604,"twenty":9.388706,"median":10.31924,"eighty":12.150743,"marketCap":272255603890.7},{"date":"2024-02-09","current":9.957996,"twenty":9.394266,"median":10.32256,"eighty":12.150743,"marketCap":299960785015.74},{"date":"2024-02-16","current":10.230695,"twenty":9.394266,"median":10.32256,"eighty":12.150743,"marketCap":306411060067.22},{"date":"2024-02-23","current":10.551341,"twenty":9.394266,"median":10.323577,"eighty":12.150743,"marketCap":315378380929.65},{"date":"2024-03-01","current":11.027814,"twenty":9.394278,"median":10.33109,"eighty":12.149015,"marketCap":331146760105.98},{"date":"2024-03-08","current":10.813788,"twenty":9.394278,"median":10.335285,"eighty":12.149015,"marketCap":328807996181.04},{"date":"2024-03-15","current":10.448336,"twenty":9.394278,"median":10.34246,"eighty":12.149015,"marketCap":317352794924.37},{"date":"2024-03-22","current":11.598612,"twenty":9.394278,"median":10.355684,"eighty":12.149015,"marketCap":344082353343.51},{"date":"2024-03-28","current":11.400908,"twenty":9.394278,"median":10.3593,"eighty":12.149015,"marketCap":339062320000.54},{"date":"2024-04-05","current":10.837354,"twenty":9.394266,"median":10.37261,"eighty":12.150743,"marketCap":321490532674.96},{"date":"2024-04-12","current":11.28055,"twenty":9.394266,"median":10.377412,"eighty":12.150743,"marketCap":331086520232.15},{"date":"2024-04-19","current":10.54688,"twenty":9.394266,"median":10.38364,"eighty":12.150743,"marketCap":306968136269.85},{"date":"2024-04-26","current":10.510945,"twenty":9.394278,"median":10.389205,"eighty":12.149015,"marketCap":304094877924.26},{"date":"2024-05-03","current":10.72356,"twenty":9.394278,"median":10.39588,"eighty":12.149015,"marketCap":313701286943.33},{"date":"2024-05-10","current":8.968812,"twenty":9.394219,"median":10.405631,"eighty":12.149015,"marketCap":284988352069.93},{"date":"2024-05-17","current":9.35894,"twenty":9.370205,"median":10.405631,"eighty":12.149015,"marketCap":298070569595.92},{"date":"2024-05-24","current":9.241817,"twenty":9.361646,"median":10.405631,"eighty":12.149015,"marketCap":290894869344.83},{"date":"2024-05-31","current":9.263607,"twenty":9.350689,"median":10.405631,"eighty":12.149015,"marketCap":292373544175.41},{"date":"2024-06-07","current":8.767878,"twenty":9.330368,"median":10.405631,"eighty":12.149015,"marketCap":277873277699.88},{"date":"2024-06-14","current":8.487327,"twenty":9.308671,"median":10.405631,"eighty":12.149015,"marketCap":267473488691.17},{"date":"2024-06-21","current":8.372928,"twenty":9.301945,"median":10.408148,"eighty":12.150743,"marketCap":260910138589.3},{"date":"2024-06-28","current":8.961267,"twenty":9.298847,"median":10.412275,"eighty":12.157656,"marketCap":275771302935.71},{"date":"2024-07-05","current":9.040257,"twenty":9.291914,"median":10.412275,"eighty":12.157656,"marketCap":277390762189.75},{"date":"2024-07-12","current":8.917686,"twenty":9.282674,"median":10.412275,"eighty":12.157656,"marketCap":278137816190.97},{"date":"2024-07-15","current":8.917686,"twenty":9.28243,"median":10.412275,"eighty":12.157656,"marketCap":279355354112.01},{"date":"2024-08-02","current":7.041317,"twenty":9.276817,"median":10.39588,"eighty":12.184402,"marketCap":231924591714.35},{"date":"2024-08-09","current":6.637283,"twenty":9.265654,"median":10.39588,"eighty":12.184402,"marketCap":223881488426.31},{"date":"2024-08-16","current":7.442706,"twenty":9.252106,"median":10.39588,"eighty":12.184402,"marketCap":248253869142.74},{"date":"2024-08-23","current":7.273214,"twenty":9.233928,"median":10.39588,"eighty":12.184402,"marketCap":247232647793.85},{"date":"2024-08-30","current":7.483383,"twenty":9.22424,"median":10.39588,"eighty":12.184402,"marketCap":255852831018.33},{"date":"2024-09-06","current":7.003384,"twenty":9.219097,"median":10.39588,"eighty":12.184402,"marketCap":242110054996.92},{"date":"2024-09-13","current":6.657621,"twenty":9.20585,"median":10.390862,"eighty":12.184402,"marketCap":232274731105.64},{"date":"2024-09-20","current":7.143045,"twenty":9.191896,"median":10.382809,"eighty":12.184402,"marketCap":248538318454.32},{"date":"2024-09-27","current":7.44525,"twenty":9.18363,"median":10.373181,"eighty":12.184402,"marketCap":255458190614.14},{"date":"2024-10-04","current":6.997426,"twenty":9.168808,"median":10.358804,"eighty":12.184402,"marketCap":236830385239.74},{"date":"2024-10-11","current":6.932484,"twenty":9.1553,"median":10.354854,"eighty":12.184402,"marketCap":231904929554.32},{"date":"2024-10-18","current":6.757684,"twenty":9.141533,"median":10.335285,"eighty":12.184402,"marketCap":223778731168.75},{"date":"2024-10-25","current":6.883439,"twenty":9.129284,"median":10.329287,"eighty":12.184402,"marketCap":225048774919.69},{"date":"2024-10-31","current":7.101856,"twenty":9.122712,"median":10.322596,"eighty":12.184402,"marketCap":231437178743.57},{"date":"2024-11-08","current":8.200075,"twenty":9.102264,"median":10.31392,"eighty":12.18547,"marketCap":228195126660.03},{"date":"2024-11-15","current":8.327889,"twenty":9.082145,"median":10.30012,"eighty":12.18547,"marketCap":227851679690.47},{"date":"2024-11-22","current":8.206235,"twenty":9.064377,"median":10.276611,"eighty":12.18547,"marketCap":226334810049.29},{"date":"2024-11-29","current":7.858213,"twenty":9.045208,"median":10.270427,"eighty":12.18547,"marketCap":221081895555.64},{"date":"2024-12-06","current":8.096901,"twenty":9.033515,"median":10.254464,"eighty":12.18547,"marketCap":229868025198.21},{"date":"2024-12-13","current":8.30787,"twenty":9.021772,"median":10.22796,"eighty":12.18547,"marketCap":232643820156.81},{"date":"2024-12-20","current":8.535778,"twenty":9.007394,"median":10.218161,"eighty":12.18547,"marketCap":230746247381.81},{"date":"2024-12-27","current":9.818531,"twenty":8.9986,"median":10.200346,"eighty":12.18547,"marketCap":264870066494.9},{"date":"2025-01-03","current":9.675442,"twenty":8.9986,"median":10.189579,"eighty":12.18547,"marketCap":261830247114.05},{"date":"2025-01-10","current":9.007894,"twenty":8.9986,"median":10.180013,"eighty":12.186538,"marketCap":243092635183.17},{"date":"2025-01-17","current":8.565487,"twenty":8.967107,"median":10.171523,"eighty":12.186538,"marketCap":235114492848.26},{"date":"2025-01-24","current":8.855817,"twenty":8.961267,"median":10.165658,"eighty":12.186538,"marketCap":242008458741.27},{"date":"2025-01-31","current":9.135393,"twenty":8.957202,"median":10.141395,"eighty":12.186538,"marketCap":252298057008.53},{"date":"2025-02-07","current":7.246926,"twenty":8.947648,"median":10.131987,"eighty":12.186538,"marketCap":243295591170.03},{"date":"2025-02-14","current":7.195611,"twenty":8.947648,"median":10.131987,"eighty":12.186538,"marketCap":239862178438.66},{"date":"2025-02-21","current":6.942886,"twenty":8.947648,"median":10.131987,"eighty":12.186538,"marketCap":236481636207.77},{"date":"2025-02-28","current":6.899269,"twenty":8.947648,"median":10.131987,"eighty":12.186538,"marketCap":234522781422.4},{"date":"2025-03-07","current":7.181905,"twenty":8.952256,"median":10.133998,"eighty":12.187463,"marketCap":247050876999.6},{"date":"2025-03-14","current":7.03714,"twenty":8.952256,"median":10.133998,"eighty":12.187463,"marketCap":242985940371.29},{"date":"2025-03-21","current":7.288238,"twenty":8.952256,"median":10.133998,"eighty":12.187463,"marketCap":249726240097.54},{"date":"2025-03-28","current":6.919278,"twenty":8.952256,"median":10.133998,"eighty":12.187463,"marketCap":233662092178.64},{"date":"2025-04-04","current":6.162183,"twenty":8.952256,"median":10.133998,"eighty":12.187463,"marketCap":215308987506.32},{"date":"2025-04-11","current":6.194178,"twenty":8.947648,"median":10.131987,"eighty":12.186538,"marketCap":218785571059.41},{"date":"2025-04-17","current":6.395105,"twenty":8.947648,"median":10.131987,"eighty":12.186538,"marketCap":229351374300.22},{"date":"2025-04-25","current":6.885264,"twenty":8.952256,"median":10.133998,"eighty":12.187463,"marketCap":246031968895.36},{"date":"2025-05-02","current":7.106778,"twenty":8.952256,"median":10.133998,"eighty":12.187463,"marketCap":249213599815.24},{"date":"2025-05-09","current":7.437943,"twenty":8.952256,"median":10.133998,"eighty":12.187463,"marketCap":244240265458.25},{"date":"2025-05-16","current":7.227345,"twenty":8.952256,"median":10.133998,"eighty":12.187463,"marketCap":236183901810.15},{"date":"2025-05-23","current":7.175379,"twenty":8.952256,"median":10.133998,"eighty":12.187463,"marketCap":237806187933.75},{"date":"2025-05-30","current":7.573327,"twenty":8.942194,"median":10.133998,"eighty":12.187463,"marketCap":250196249736.93},{"date":"2025-06-06","current":7.253328,"twenty":8.917141,"median":10.133998,"eighty":12.187463,"marketCap":240568591737.01},{"date":"2025-06-13","current":6.988029,"twenty":8.896562,"median":10.133998,"eighty":12.187463,"marketCap":231679210496.78},{"date":"2025-06-20","current":6.844439,"twenty":8.874332,"median":10.13429,"eighty":12.188387,"marketCap":223775204425.4},{"date":"2025-06-27","current":6.911447,"twenty":8.854761,"median":10.13429,"eighty":12.188387,"marketCap":227922345870.74},{"date":"2025-07-03","current":6.869054,"twenty":8.832895,"median":10.13429,"eighty":12.188387,"marketCap":225981638453.82},{"date":"2025-07-11","current":6.859481,"twenty":8.818202,"median":10.13429,"eighty":12.188387,"marketCap":223205689863.85},{"date":"2025-07-18","current":6.881362,"twenty":8.755943,"median":10.13429,"eighty":12.188387,"marketCap":220798069049.78},{"date":"2025-07-25","current":7.622558,"twenty":8.72522,"median":10.13429,"eighty":12.188387,"marketCap":247481668440},{"date":"2025-08-01","current":7.451617,"twenty":8.675821,"median":10.13429,"eighty":12.188387,"marketCap":235893267000.58},{"date":"2025-08-08","current":8.457965,"twenty":8.591357,"median":10.129531,"eighty":12.169091,"marketCap":245167376130.22},{"date":"2025-08-15","current":8.705024,"twenty":8.549275,"median":10.11015,"eighty":12.131916,"marketCap":251818018551.78},{"date":"2025-08-22","current":8.976484,"twenty":8.549275,"median":10.097345,"eighty":12.100682,"marketCap":258887369440.83},{"date":"2025-08-29","current":8.762976,"twenty":8.549275,"median":10.086949,"eighty":12.029251,"marketCap":254691051237.66},{"date":"2025-09-05","current":9.035961,"twenty":8.546128,"median":10.073721,"eighty":11.996899,"marketCap":259717499918.27},{"date":"2025-09-12","current":8.811778,"twenty":8.549275,"median":10.058874,"eighty":11.962956,"marketCap":255832771462.94},{"date":"2025-09-19","current":8.915482,"twenty":8.549275,"median":10.046043,"eighty":11.826465,"marketCap":257529541517.41},{"date":"2025-09-26","current":9.057312,"twenty":8.549275,"median":10.036139,"eighty":11.659912,"marketCap":258443271914.81},{"date":"2025-10-03","current":8.660797,"twenty":8.549275,"median":10.023168,"eighty":11.568256,"marketCap":251082563433.89},{"date":"2025-10-10","current":8.840754,"twenty":8.549275,"median":10.003584,"eighty":11.452811,"marketCap":246650808761.59},{"date":"2025-10-17","current":8.947508,"twenty":8.549275,"median":9.979594,"eighty":11.337752,"marketCap":253592982643.91},{"date":"2025-10-24","current":9.537705,"twenty":8.549275,"median":9.967773,"eighty":11.28055,"marketCap":266870625343.7},{"date":"2025-10-31","current":9.571256,"twenty":8.549275,"median":9.958289,"eighty":11.209109,"marketCap":265411053652.74},{"date":"2025-11-07","current":8.774478,"twenty":8.549275,"median":9.945195,"eighty":11.180772,"marketCap":265409055839.35},{"date":"2025-11-14","current":8.948954,"twenty":8.549275,"median":9.929547,"eighty":11.080493,"marketCap":268538147702.6},{"date":"2025-11-21","current":8.715381,"twenty":8.538212,"median":9.925171,"eighty":11.0091,"marketCap":256286827122.06},{"date":"2025-11-28","current":8.81669,"twenty":8.538212,"median":9.90985,"eighty":10.993116,"marketCap":261289943005.86},{"date":"2025-12-05","current":8.532462,"twenty":8.530036,"median":9.8995,"eighty":10.967688,"marketCap":255346933696.96},{"date":"2025-12-12","current":9.174085,"twenty":8.530036,"median":9.882026,"eighty":10.944626,"marketCap":273667846563.7},{"date":"2025-12-19","current":9.635604,"twenty":8.530036,"median":9.877292,"eighty":10.923873,"marketCap":287107870130.45},{"date":"2025-12-26","current":9.511782,"twenty":8.530036,"median":9.865354,"eighty":10.903594,"marketCap":282368379100.45},{"date":"2026-01-02","current":9.444242,"twenty":8.530036,"median":9.850316,"eighty":10.894285,"marketCap":279079016263.41},{"date":"2026-01-09","current":9.534295,"twenty":8.530036,"median":9.842475,"eighty":10.876951,"marketCap":281377428911.71},{"date":"2026-01-16","current":10.327881,"twenty":8.530036,"median":9.835746,"eighty":10.857459,"marketCap":301858755734.76},{"date":"2026-01-23","current":10.198431,"twenty":8.530036,"median":9.835746,"eighty":10.845279,"marketCap":298327517461.79},{"date":"2026-01-30","current":9.860734,"twenty":8.530036,"median":9.821374,"eighty":10.833289,"marketCap":298603364827.03},{"date":"2026-02-06","current":10.637434,"twenty":8.530036,"median":9.821374,"eighty":10.80613,"marketCap":313859436118.34},{"date":"2026-02-13","current":13.309926,"twenty":8.530036,"median":9.821374,"eighty":10.80613,"marketCap":322679691855.59},{"date":"2026-02-20","current":12.819708,"twenty":8.530036,"median":9.821374,"eighty":10.80613,"marketCap":305795987508.04},{"date":"2026-02-27","current":13.48979,"twenty":8.530036,"median":9.821374,"eighty":10.80613,"marketCap":319159438097.15},{"date":"2026-03-06","current":12.396499,"twenty":8.530036,"median":9.821374,"eighty":10.80613,"marketCap":290370625620.55},{"date":"2026-03-13","current":11.885122,"twenty":8.530036,"median":9.821374,"eighty":10.80613,"marketCap":275846668111.07},{"date":"2026-03-20","current":11.726418,"twenty":8.530036,"median":9.821374,"eighty":10.80613,"marketCap":274144947508.33},{"date":"2026-03-27","current":12.019138,"twenty":8.530036,"median":9.821374,"eighty":10.80613,"marketCap":278207544709.07},{"date":"2026-04-02","current":11.504234,"twenty":8.530036,"median":9.821374,"eighty":10.80613,"marketCap":266895849834.11},{"date":"2026-04-10","current":11.705258,"twenty":8.530036,"median":9.821374,"eighty":10.80613,"marketCap":271784788749.28},{"date":"2026-04-17","current":11.7899,"twenty":8.530036,"median":9.821374,"eighty":10.80613,"marketCap":273739770735.08},{"date":"2026-04-24","current":10.816519,"twenty":8.530036,"median":9.821374,"eighty":10.80613,"marketCap":250804029913.91},{"date":"2026-05-01","current":10.58067,"twenty":8.530036,"median":9.821374,"eighty":10.804477,"marketCap":249475525227.13},{"date":"2026-05-08","current":10.27383,"twenty":8.530036,"median":9.821374,"eighty":10.789706,"marketCap":242686668031.95},{"date":"2026-05-15","current":10.448796,"twenty":8.530036,"median":9.813058,"eighty":10.78211,"marketCap":254250843238.65},{"date":"2026-05-22","current":10.116873,"twenty":8.530036,"median":9.813058,"eighty":10.770839,"marketCap":244551983917.77},{"date":"2026-05-29","current":10.303156,"twenty":8.528822,"median":9.810851,"eighty":10.746414,"marketCap":249026792097.91},{"date":"2026-06-05","current":9.652859,"twenty":8.530036,"median":9.790714,"eighty":10.730763,"marketCap":232162965017.25},{"date":"2026-06-12","current":9.400529,"twenty":8.530036,"median":9.776577,"eighty":10.722324,"marketCap":225409445343.32},{"date":"2026-06-18","current":9.461495,"twenty":8.530036,"median":9.756873,"eighty":10.712432,"marketCap":226168054168.62},{"date":"2026-06-26","current":8.517464,"twenty":8.518484,"median":9.744733,"eighty":10.694148,"marketCap":202764288143.33},{"date":"2026-07-02","current":8.594392,"twenty":8.46971,"median":9.720598,"eighty":10.684972,"marketCap":205548036688.17},{"date":"2026-07-10","current":8.686706,"twenty":8.46971,"median":9.699282,"eighty":10.660921,"marketCap":205879997686.52},{"date":"2026-07-17","current":8.922105,"twenty":8.46971,"median":9.675442,"eighty":10.645845,"marketCap":211339353408.91},{"date":"2026-07-24","current":8.914412,"twenty":8.46971,"median":9.660114,"eighty":10.632603,"marketCap":209329981292},{"date":"2026-07-31","current":9.437522,"twenty":8.463837,"median":9.648212,"eighty":10.617627,"marketCap":227758266571.16},{"date":"2026-08-07","current":7.870264,"twenty":8.402034,"median":9.643002,"eighty":10.611709,"marketCap":222762283048.22},{"date":"2026-08-14","current":7.975905,"twenty":8.375064,"median":9.643002,"eighty":10.611709,"marketCap":224396770135.09},{"date":"2026-08-21","current":8.2717,"twenty":8.315982,"median":9.643002,"eighty":10.611709,"marketCap":233618820103.18},{"date":"2026-08-28","current":8.229443,"twenty":8.292471,"median":9.643002,"eighty":10.611709,"marketCap":231621473400.96}],"updateTime":1788154940647},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TM\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2659314135","title":"Press Release: Quoin Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2659314135","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659314135?lang=en_us&edition=fundamental","pubTime":"2026-08-14 20:30","pubTimestamp":1786710600,"startTime":"0","endTime":"0","summary":"-- Receives FDA Conditional Approval of QYLEKI(TM) as the Proposed Brand Name for QRX003 for Netherton Syndrome-- Reports Positive Clinical Update from Ongoing Pediatric Compassionate Use Program in N","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4555","BK4099","BK4139","BK4585","QNRX","TM","03160","BK4588","BK4604"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659203146","title":"Press Release: Evaxion to Announce Business Update and Second Quarter 2026 Financial Results on August 20, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2659203146","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659203146?lang=en_us&edition=fundamental","pubTime":"2026-08-14 20:00","pubTimestamp":1786708800,"startTime":"0","endTime":"0","summary":"COPENHAGEN, Denmark, August 14, 2026 - Evaxion A/S (NASDAQ: EVAX) (\"Evaxion\"), a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology(TM) platform, will provide a","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QTOC","BK4585","AIPO","BK4099","ARTY","BK4555","AGIX","BK4604","EVAX","TM","VTHR","BK4139","BK4588","03160","CHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659450691","title":"Press Release: Lantern Pharma Reports Second Quarter 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2659450691","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659450691?lang=en_us&edition=fundamental","pubTime":"2026-08-14 19:30","pubTimestamp":1786707000,"startTime":"0","endTime":"0","summary":"Open Medicine AI Established as a Separate Company with Executed Commercial Licenses; Progression-Free Survival Benefit Deepens in EGFR Exon 21 L858R Lung Cancer with LP-300; EMA Clears LP-184, zirdafulven, for Biomarker-Selected Bladder Cancer Trial; LP-184 Development Positioned to Advance in Multiple Indications including Triple Negative Breast Cancer and Pediatric Brain Cancers--  Open Medicine AI  established as a separate company with. withZeta.ai. OMAI is currently wholly owned by Lantern and intends to. raise capital at the OMAI level. A dedicated OMAI informational call is. planned for mid-September 2026 to detail the market opportunity, platform. --  LP-300 -- HARMONIC benefit deepens with treatment duration in. emerging dataset: Median progression-free survival of 8.9 months in EGFR. exon 21 L858R patients who completed six cycles of LP-300 (n=9), compared. with 8.4 months across the overall L858R cohort , and a hazard. clinical benefit rate and tumor reduction in more than ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4099","LTRN","BK4555","BK4232","ARTY","AGIX","03160","BK4604","VGT","AIPO","BK4588","BK4585","VTHR","BK4081","R","BK4022","EMA","CHAT","QTOC","BK4139","TM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659145061","title":"Press Release: Milestone Scientific Reports Financial Results for Second Quarter 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2659145061","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659145061?lang=en_us&edition=fundamental","pubTime":"2026-08-14 19:30","pubTimestamp":1786707000,"startTime":"0","endTime":"0","summary":"Medical Segment Revenue Grows 231% Year-Over-YearEnters Strategic Distribution Agreement to Expand CompuFlo(R) Access Across VA and Department of Defense Health SystemsReaffirms 2026 Outlook for Doubl","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4179","BK4604","BK4585","IE00B66KJ199.SGD","BK4588","BK4555","BK4232","BK4022","IE00B19Z4B17.USD","BK4109","TM","MLSS","IE0031619046.USD","IE00B7SZL793.SGD","R","03160","ASPN","BK4099","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659145220","title":"Press Release: Helus Pharma Reports First Quarter Fiscal 2027 Financial Results and Recent Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2659145220","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659145220?lang=en_us&edition=fundamental","pubTime":"2026-08-14 19:28","pubTimestamp":1786706880,"startTime":"0","endTime":"0","summary":"- Appointed Michael Halstead, former President of Intra-Cellular Therapies, as Chief Executive Officer to lead Helus Pharma through late-stage development and commercialization -- Completed enrollment","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4099","BK4588","03160","BK4555","BK4585","BK4604","TM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659145631","title":"Press Release: Payward Reports Second Quarter 2026 Adjusted Revenue of $508 Million, up 17% Year over Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2659145631","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659145631?lang=en_us&edition=fundamental","pubTime":"2026-08-14 19:14","pubTimestamp":1786706040,"startTime":"0","endTime":"0","summary":"Funded accounts grew 42% to 6.6 million; asset-based and other revenue. reached 60% of total revenue as growth broadened beyond trading. Payward, Inc., the unified financial infrastructure platform behind a. family of products including Kraken, today reported financial results. for the second quarter ended June 30, 2026.year, and remained Adjusted EBITDA positive at $23 million. Growth was. broad-based across the company's four business pillars. As crypto spot. volumes declined across the industry,[1] Payward's traditional futures,equities and tokenized equities activity grew, and the company gained. spot market share for the third consecutive quarter.\"Three forces are rearranging global markets: convergence across asset. classes, the onshoring of activity into regulated venues, and the. automation of market participation,\" said Arjun Sethi, Co-CEO of. Payward. \"Each rewards the same decision we made years ago -- to build. one platform rather than a collection of products. One matching","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DIME","NCIQ","BK4604","GDLC","BK4555","APT.USD.CC","BK4099","TEKX","BK4588","DAPP","STCE","BKCH","BITW","TON.USD.CC","LFGY","TM","03160","BITQ","BK4585","CRPT","APT.USD.HKCC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659145865","title":"Press Release: Quantum BioPharma Strengthens Equity and Liquidity in Q2 2026 as FDA Approves Lucid-MS for Pivotal Phase 2 Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2659145865","media":"Dow Jones","labels":["corporation","productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659145865?lang=en_us&edition=fundamental","pubTime":"2026-08-14 19:00","pubTimestamp":1786705200,"startTime":"0","endTime":"0","summary":"US$9.5 million as of June 30, 2026, increased from US$4.1 million as of. -- Cash and cash equivalents nearly doubled to US$3.65 million, up from. -- Total shareholders' equity increased to US$6.09 million, up approximately. 19% from US$5.10 million at December 31, 2025, reflecting a strengthened. -- Working capital improved significantly to approximately US$1.66 million. as of June 30, 2026, up from approximately US$0.42 million at December. 31, 2025, indicating strengthened short-term liquidity and full coverage. -- Quick ratio of 1.19 as of June 30, 2026, compared to 1.06 as of December. divided by current liabilities), confirming robust liquidity even on a. December 31, 2025. Importantly, approximately 47% of current liabilities,items, reflecting the Company's strong balance sheet management.Reduced Cash Burn and Cost Discipline-- Total operating expenses decreased by 53% in the second quarter of 2026. compared to the same period in 2025, to US$2.29 million from US$4.85. -- General ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1791710582.SGD","LU1989772923.USD","BK4585","LU0390134368.USD","LU1244550577.SGD","LU1732800096.USD","LU0314104364.USD","IND","LU0912757837.SGD","NVIB","EQR","LU1244550221.USD","LU1244550494.USD","LCIZ","LU0006306889.USD","LU0053666078.USD","LU2133065610.SGD","LU0234570918.USD","LU0098860793.USD","BK4551","BK4596","BK4581","LU1732799900.SGD","LU2023251221.USD","LU0158827948.USD","BK4516","03160","LU0210528500.USD","LU2089283258.USD","LU2111349929.HKD","REZ","LCID","LU2264538146.SGD","IE00B775SV38.USD","LCDL","LU0106261372.USD","VMRK","BK4099","LU1791710400.SGD","LU2357305700.SGD","LU0267386448.USD","IAI","LU1548497426.USD","LU1988902786.USD","QNTM","BK4127","LU0795875169.SGD","LABU","KBWB","LU0106831901.USD","TM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659419622","title":"Press Release: BTQ Technologies Announces 2026 AGM Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2659419622","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659419622?lang=en_us&edition=fundamental","pubTime":"2026-08-14 08:32","pubTimestamp":1786667520,"startTime":"0","endTime":"0","summary":"VANCOUVER, BC, Aug. 13, 2026 /PRNewswire/ -- BTQ Technologies Corp.   , a global technology company building the trust infrastructure for the quantum era, is pleased to provide the voting results from the 2026 Annual Meeting of shareholders. The Company announces that the nominees listed in the management proxy circular dated June 29, 2026  for the 2026 annual meeting of shareholders of the Company  were elected as directors of the Company.Detailed results of the vote for the election of directors held at the Meeting on August 12, 2026 in Vancouver, British Columbia are set out below.Fixing Number of Directors at five The number of directors of the Company was fixed at five . The results of the votes cast are set out below:Votes For      % For     Votes Against    % Against. 47,773,250    92.32 %      3,973,272       7.68 %No other business was voted upon at the Meeting.A total of 70,852,597 common shares were voted in connection with the Meeting, representing approximately 49.97% of t","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QTUP","BK4195","BK4097","BK4229","BK4588","BTQ","TM","QPUX","03160","BK4099","BK4127","BK4555","BK4604","AGM","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659216764","title":"Press Release: Genelux Corporation Reports Second Quarter Financial Results and Provides Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2659216764","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659216764?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:20","pubTimestamp":1786652400,"startTime":"0","endTime":"0","summary":"open-label Phase 3 registrational trial being conducted at sites across. the United States, with topline data anticipated in the second half of. -- The trial is evaluating Olvi-Vec followed by platinum-doublet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TM","BK4555","03160","BK4604","PLTM","BK4585","BK4139","BK4588","BK4099","GNLX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659673211","title":"Press Release: Tri Pointe Homes, Inc. Reports 2026 Second Quarter Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2659673211","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659673211?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:15","pubTimestamp":1786652100,"startTime":"0","endTime":"0","summary":"INCLINE VILLAGE, Nev., Aug. 13, 2026  -- Tri Pointe Homes, Inc.  today announced results for the second quarter ended June 30, 2026.Results and Operational Data for Second Quarter 2026 and Comparisons to Second Quarter 2025-- Home sales revenue of $685.1 million compared to $879.8 million. -- New home deliveries of 1,013 homes compared to 1,326 homes. -- Average sales price of homes delivered of $676,000 compared to. -- Homebuilding gross margin percentage of 18.0% compared to 20.8%.Excluding inventory-related charges of $19.7 million, our homebuilding. -- Excluding interest and impairments and lot option abandonments,-- SG&A expense as a percentage of home sales revenue of 32.5% compared to. -- Loss before income taxes was $165.3 million compared to income before. of availability under our revolving credit facility*  See \"Reconciliation of Non-GAAP Financial Measures\"About Tri Pointe Homes, Inc.One of the largest homebuilders in the U.S., Tri Pointe Homes, Inc. has a presence in 13 st","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03160","SRU.SI","BK4232","BK4604","BK4555","GLS.SI","JJJ.SI","BK4585","BK4099","TM","SRT.SI","BK4588","R","CFA.SI","CLR.SI","BK4022"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659162435","title":"Press Release: Xos Extends Gross Profit Streak, Highlighting Operational Efficiency","url":"https://stock-news.laohu8.com/highlight/detail?id=2659162435","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659162435?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:10","pubTimestamp":1786651800,"startTime":"0","endTime":"0","summary":"revenue in the second quarter, compared to 135 units and $18.4 million in. Q2 2025, as the Company continued its strategic focus on powertrain and. -- Gross margins improved to 12.1%, compared to 8.9% in Q2 2025. Non-GAAP. gross margin improved to 7.2%, compared to 1.5% in Q2 2025, reflecting. the Company's continued inventory discipline and a more favorable product. -- Operating loss increased to $7.9 million in Q2 2026, compared to $7.1. million in Q2 2025 while Non-GAAP operating loss improved 9.5%. year-over-year to $6.2 million in Q2 2026, compared to $6.8 million in Q2. -- Second quarter operating expenses were $8.5 million in Q2 2026, down 2.1%. year-over-year and down 5.4% sequentially from Q1 2026. The reduction. reflects continued operational efficiency and cost discipline across the. under its at-the-market offering program and its registered direct. reinforcing liquidity and providing additional capital to support. revenue in the first half of 2026, compared to 164 units an","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07366","TSYY","07766","BK4604","BK4585","03160","TSII","TSLO","BK4555","TM","TSLT","TSDD","BK4588","09366","TSLY","BK4149","TSLI","TSLG","TSLZ","XOS","BK4099","TSLS","TSLP","TESL","CRSH","TSLR","TLA","TSL","TSLL","TSLW","TEST","TSLQ","09766","ELOL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659162466","title":"Press Release: Celcuity Inc. Reports Release of Second Quarter 2026 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2659162466","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659162466?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:06","pubTimestamp":1786651560,"startTime":"0","endTime":"0","summary":"-- REVTORPYK  approved by the U.S. FDA for the treatment of. HR+/HER2- PIK3CA Wild-Type locally advanced or metastatic breast cancer. on July 14, 2026; on track for commercial launch late third quarter 2026. -- NCCN Clinical Practice Guidelines recommended REVTORPYK in combination. with fulvestrant, with or without palbociclib, as a preferred Category 1. option for second-line therapy in HR+/HER2- advanced breast cancer. -- The Phase 3 PIK3CA mutant cohort of the VIKTORIA-1 trial achieved its. primary endpoint by doubling the likelihood of survival without disease. progression or death compared to alpelisib plus fulvestrant; a. supplemental New Drug Application  is planned for submission in","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03160","BK4604","CELC","BK4139","TM","BK4232","BK4585","R","BK4555","BK4099","BK4022","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659959162","title":"Press Release: Quantum-Si Reports Second Quarter 2026 Financial Results and Provides Proteus(TM) Development Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2659959162","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659959162?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:05","pubTimestamp":1786651500,"startTime":"0","endTime":"0","summary":"Company updates anticipated commercial launch of Proteus to Q2 2027, cost-reduction actions expected to extend cash runway into Q4 2028 and highlights estimated new market opportunities for protein sequencingBRANFORD, Conn., Aug. 13, 2026  -- Quantum-Si Incorporated  , a proteomics technology company redefining protein analysis through single-molecule protein sequencing, today announced financial results for the second quarter ended June 30, 2026.Press Release Highlights-- Reported second quarter 2026 revenue of $344 thousand during the Proteus. -- Updated anticipated Proteus launch timeline to Q2 2027 to incorporate an. additional integrated instrument design cycle focused on manufacturing. readiness, system repeatability, and customer experience at launch.-- Highlighted an estimated $4 billion non-human proteomics market. -- Announced a reduction in force of approximately 20% of the Company's. workforce to align resources and spending with the updated Proteus launch","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4555","QSI","BK4121","BK4604","03160","BK4585","TM","BK4588","BK4099"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659816250","title":"Press Release: Swarmer Reports Second Quarter 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2659816250","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659816250?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:05","pubTimestamp":1786651500,"startTime":"0","endTime":"0","summary":"contracted license value from $2.9 million to $3.9 million. Existing. customer upgrade options, if fully exercised, would bring the maximum. -- Partnered with Oak Grove Technologies to integrate Swarmer's autonomy. software into the Chimera UAV platform, advancing autonomous swarming. capabilities for U.S. Special Operations and defense missions.-- Signed an MOU with Powerus to explore the integration of Swarmer's. autonomy and swarming software across air and maritime autonomous. -- Collaborated with Lantronix to develop a custom NDAA-compliant compute. platform for Group 1 unmanned aerial systems, increasing onboard. -- Partnered with Brightline Interactive to integrate Swarmer's autonomy. software with Brightline's platform and expand access to operational data. -- Established a strategic data partnership with Molfar Intelli","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QQH","03160","VGT","IGM","BK4555","BK4604","BK4585","BK4187","BK4588","TM","BK4099","SWMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659629201","title":"Press Release: Vivani Medical Reports Second Quarter 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2659629201","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659629201?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:05","pubTimestamp":1786651500,"startTime":"0","endTime":"0","summary":"All participants successfully dosed in SLIM-1(TM), the Company's first-in-human Phase 1 trial of NPM-139, a miniature, ultra long-acting semaglutide implant for chronic weight management; top-line dat","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4555","BK4585","VANI","CRGT","BK4022","TM","03160","BK4604","BK4588","BK4232","BK4099","R"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659216257","title":"Press Release: Fortress Biotech Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2659216257","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659216257?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:05","pubTimestamp":1786651500,"startTime":"0","endTime":"0","summary":"Total net revenue increased 14% to $18.7 million for second quarter of 2026 compared to second quarter of 2025Partnered programs continue to advance with Crystalys Therapeutics announcing its $130 mil","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03160","BK4588","BK4232","DERM","BK4585","BK4139","BK4604","BK4555","R","XBI","BK4581","TM","HELS","BK4007","FBIO","BK4099","BK4022"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659162134","title":"Press Release: CapsoVision Reports Second Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2659162134","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659162134?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:05","pubTimestamp":1786651500,"startTime":"0","endTime":"0","summary":"SARATOGA, Calif., Aug. 13, 2026  -- CapsoVision, Inc. , a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions, today reported financial results and provided a business update for its second quarter ended June 30, 2026.Recent Highlights-- Reported second quarter 2026 revenue was $3.6 million, up 10% year over. -- CapsoCam Plus used by over 176,000 patients as of June 30, 2026.-- Launched AI Highlights, the AI-assisted reading feature for CapsoCam. Plus, commercially in the European Union and other international. markets to support physician review of small bowel capsule endoscopy. -- Anticipate FDA clearance of AI Highlights by the end of the third. quarter of 2026, with U.S. commercial launch expected shortly thereafter.-- Continued commercial momentum with expanding adoption across large. hospital systems and GI networks, including key customer renewals and. -- Pipeline continues to advance with CapsoCam Colon on track for","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QTOC","BK4604","BK4588","BK4082","BK4099","TM","CHAT","BK4022","ARTY","AIPO","BK4585","CV","R","03160","VTHR","AGIX","BK4232","BK4555"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659683162","title":"Press Release: Kyntra Bio Reports Second Quarter 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2659683162","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659683162?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:02","pubTimestamp":1786651320,"startTime":"0","endTime":"0","summary":"-- Phase 2 monotherapy trial of FG-3246, a potential first-in-class antibody. prostate cancer , continues enrolling with interim analysis on. -- Phase 3 protocol of roxadustat for the treatment of anemia in patients. burden  has been finalized with the goal to initiate the. -- Additional data from the Phase 3 MATTERHORN study were presented at the. improvements in transfusion independence in patients with HTB and. -- Cash, cash equivalents, investments, and accounts receivable of $95.7. -- Kyntra Bio to host conference call and webcast presentation today at 5:00. first-in-class ADC targeting CD46 in mCRPC continues; interim analysis is. on track for the fourth quarter of 2026.Roxadustat-- Pivotal Phase 3 trial protocol of roxadustat for the treatment of anemia. in patients with LR-MDS and high transfusion burden  has been. -- In a post hoc analysis of the Phase 3 MATTERHORN study, patients. treated with roxadustat showed a clinically meaningful improvement. in transfusion independence ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4206","BK4604","BK4022","BK4139","BK4080","BK4232","BK4099","LU2236285917.USD","HTB","R","LU1267930490.SGD","LU0128525689.USD","03160","LU0310800965.SGD","BK4231","LU1267930227.SGD","BK4109","ADC","NETL","TM","LU0310799852.SGD","BK4555","BK4585","LU0211328371.USD","BK4211","KYNB","BK4504","LU0211327993.USD","LU0052756011.USD","BK4588","DD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659815471","title":"Press Release: Cingulate Inc. Reports Second Quarter 2026 Financial Results and Provides Update on CTx-1301 CMC Progress Towards NDA Resubmission and Commercial Readiness","url":"https://stock-news.laohu8.com/highlight/detail?id=2659815471","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659815471?lang=en_us&edition=fundamental","pubTime":"2026-08-13 20:30","pubTimestamp":1786624200,"startTime":"0","endTime":"0","summary":"contract development and manufacturing organization, to complete the. requested CMC work and advance process validation for CTx-1301, which. -- Product Distribution: On July 21, 2026, the Company signed an exclusive. services agreement with Prasco, LLC to establish the commercial. distribution infrastructure for the launch of CTx-1301, providing. designed to support broad national availability across maj","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0149725797.USD","BK4099","LU2237443382.USD","03160","IE00BFXG1179.USD","BK4604","CMC","BK4007","BK4585","BK4139","IE00B1BXHZ80.USD","LU2237443895.HKD","BK4097","LU0170899867.USD","BK4006","LU0971096721.USD","LU2237443978.SGD","LU2237443465.HKD","LU0267386448.USD","LU2746668461.USD","BK4588","LU0882574139.USD","LU1363072403.SGD","TM","LU2746668974.SGD","LU2237443549.SGD","LU2065732104.USD","BK4555","PRGS","ABVC","IE00BKVL7J92.USD","IE00BHPRN162.USD","CING","ADHD","IE00BZ1G4Q59.USD","LU2237443622.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659461159","title":"Press Release: Bragg Gaming Group Reports Second Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2659461159","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659461159?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:30","pubTimestamp":1786620600,"startTime":"0","endTime":"0","summary":"TORONTO----August 13, 2026--Bragg Gaming Group  , a leading igaming content and platform technology solutions provider, today announced its financial results for the second quarter of 2026.Second Quarter 2026 Financial Highlights--  Revenue: Total quarterly revenue of EUR 22.9m 1 in the. second quarter, a decrease of 12% from EUR 26.1m  in the. --  The Netherlands revenue declined 14% year-over-year, reflecting. the anticipated roll-off of legacy platform contracts following. United States grew 44% year-over-year, and 25% from 1Q26; and. --  Brazil revenue was flat compared to the second quarter of 2025,as certain operators moved to direct supplier integrations.--  Operating loss for the second quarter was EUR 1.9m , a. EUR 0.4m  improvement from an operating loss of EUR 2.3m.  in the same period of 2025, as reduced operating. --  Net loss for the second quarter was EUR 2.9m , or EUR. or EUR 0.07  per common share, in the same period of. measures, see \"Other Financial Information\" belo","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4099","TM","03160","CROC","BK4150","BK4555","EUFX","BK4585","BK4604","BRAG","USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":6,"totalSize":200,"code":"91000000","status":"200"}]}}